Long term exposure to antiangiogenic therapy, bevacizumab, induces osteonecrosis
Crossref DOI link: https://doi.org/10.1007/s10637-015-0283-x
Published Online: 2015-08-28
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tabouret, Tessa
Gregory, Thomas
Dhooge, Marion
Brezault, Catherine
Mir, Olivier
Dréanic, Johann
Chaussade, Stanislas
Coriat, Romain
Text and Data Mining valid from 2015-08-28
Version of Record valid from 2015-08-28
Article History
Received: 13 July 2015
Accepted: 20 August 2015
First Online: 28 August 2015